High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for herd immunity!

Susy Fanny Núñez-Zapata, Bruno Benites-Peralta, Percy Mayta-Tristan, Alfonso J. Rodríguez-Morales

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

12 Citas (Scopus)

Resumen

Herd immunity is considered to be a relevant aspect of COVID-19 epidemiology. In this regard, seroprevalence studies are essential for understanding how far countries and regions are from that potential point. This study analyzed seroprevalence data in nine studies from South America, which is a region that has been badly affected by COVID-19. Seroprevalence values ​​were high, with percentages up to 70.0% (95% CI 67.0-73.4%) in Iquitos, Peru. A meta-analysis of such data enabled a pooled seroprevalence to be obtained, estimated at 33.6% (95% CI 28.6-38.5%). Despite this, the COVID-19 pandemic in South America continues to significantly affect countries such as Brazil, Colombia, and Peru.

Idioma originalInglés
Páginas (desde-hasta)244-246
Número de páginas3
PublicaciónInternational Journal of Infectious Diseases
Volumen109
DOI
EstadoPublicada - ago. 2021

Huella

Profundice en los temas de investigación de 'High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for herd immunity!'. En conjunto forman una huella única.

Citar esto